Take Solutions Limited (TAKE) - Total Assets
Based on the latest financial reports, Take Solutions Limited (TAKE) holds total assets worth Rs352.13 Million INR (≈ $3.81 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See TAKE net asset value for net asset value and shareholders' equity analysis.
Take Solutions Limited - Total Assets Trend (2002–2025)
This chart illustrates how Take Solutions Limited's total assets have evolved over time, based on quarterly financial data.
Take Solutions Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Take Solutions Limited's total assets of Rs352.13 Million consist of 64.6% current assets and 35.4% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs29.50 Million | 9.2% |
| Accounts Receivable | Rs587.52 Million | 161.1% |
| Inventory | Rs1.08 Million | 0.3% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs80.00K | 0.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2002–2025)
This chart illustrates how Take Solutions Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see TAKE stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Take Solutions Limited's current assets represent 64.6% of total assets in 2025, an increase from 0.0% in 2002.
- Cash Position: Cash and equivalents constituted 9.2% of total assets in 2025, up from 8.2% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
- Asset Diversification: The largest asset category is accounts receivable at 161.1% of total assets.
Take Solutions Limited Competitors by Total Assets
Key competitors of Take Solutions Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Argen-X
F:1AE
|
Germany | €7.18 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233
|
China | CN¥26.08 Billion |
|
Staidson Beijing Biopharma
SHE:300204
|
China | CN¥1.26 Billion |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287
|
China | CN¥6.64 Billion |
|
Ardelyx Inc
NASDAQ:ARDX
|
USA | $486.17 Million |
|
Xiangxue Pharmaceutical
SHE:300147
|
China | CN¥7.36 Billion |
Take Solutions Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.33 | 0.72 | 1.56 |
| Quick Ratio | 2.33 | 0.72 | 1.56 |
| Cash Ratio | 0.02 | 0.01 | 0.00 |
| Working Capital | Rs127.04 Million | Rs-280.88 Million | Rs3.47 Billion |
Take Solutions Limited - Advanced Valuation Insights
This section examines the relationship between Take Solutions Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 25.44 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | -58.6% |
| Total Assets | Rs364.79 Million |
| Market Capitalization | $67.51 Million USD |
Valuation Analysis
Below Book Valuation: The market values Take Solutions Limited's assets below their book value (0.19x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Take Solutions Limited's assets decreased by 58.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Take Solutions Limited (2002–2025)
The table below shows the annual total assets of Take Solutions Limited from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs364.79 Million ≈ $3.95 Million |
-58.60% |
| 2024-03-31 | Rs881.05 Million ≈ $9.53 Million |
-60.73% |
| 2023-03-31 | Rs2.24 Billion ≈ $24.27 Million |
-81.65% |
| 2022-03-31 | Rs12.23 Billion ≈ $132.27 Million |
-33.69% |
| 2021-03-31 | Rs18.45 Billion ≈ $199.49 Million |
-25.72% |
| 2020-03-31 | Rs24.83 Billion ≈ $268.55 Million |
+6.40% |
| 2019-03-31 | Rs23.34 Billion ≈ $252.40 Million |
+26.60% |
| 2018-03-31 | Rs18.44 Billion ≈ $199.38 Million |
+34.31% |
| 2017-03-31 | Rs13.73 Billion ≈ $148.45 Million |
+13.02% |
| 2016-03-31 | Rs12.14 Billion ≈ $131.34 Million |
+31.67% |
| 2015-03-31 | Rs9.22 Billion ≈ $99.75 Million |
+6.95% |
| 2014-03-31 | Rs8.62 Billion ≈ $93.27 Million |
+3.07% |
| 2013-03-31 | Rs8.37 Billion ≈ $90.50 Million |
+12.98% |
| 2012-03-31 | Rs7.41 Billion ≈ $80.10 Million |
+26.05% |
| 2011-03-31 | Rs5.88 Billion ≈ $63.54 Million |
+14.46% |
| 2010-03-31 | Rs5.13 Billion ≈ $55.52 Million |
-0.33% |
| 2009-03-31 | Rs5.15 Billion ≈ $55.70 Million |
+29.46% |
| 2008-03-31 | Rs3.98 Billion ≈ $43.03 Million |
+53.94% |
| 2007-03-31 | Rs2.58 Billion ≈ $27.95 Million |
+185.49% |
| 2006-03-31 | Rs905.33 Million ≈ $9.79 Million |
+364.53% |
| 2005-03-31 | Rs194.89 Million ≈ $2.11 Million |
+37.78% |
| 2004-03-31 | Rs141.45 Million ≈ $1.53 Million |
+49.33% |
| 2003-03-31 | Rs94.72 Million ≈ $1.02 Million |
+216.79% |
| 2002-03-31 | Rs29.90 Million ≈ $323.36K |
-- |
About Take Solutions Limited
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient c… Read more